Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Mycol Med ; 31(2): 101113, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33540367

RESUMEN

INTRODUCTION: Cryptococcus gattii species complex is endemic to tropical and subtropical regions and is described as a causative agent of cryptococcosis in immunocompetent individuals. CASE PRESENTATION: We describe the first case of cryptococcosis in a HIV-negative patient from Ivory Coast infected by Cryptococcus gattii sensu stricto VGI. Isolates were recovered from cerebrospinal fluid (CSF) prior to systemic antifungal treatment up to 42 days after detection of the presence of yeasts in the CSF. Eighteen isolates were recovered, genetic diversity and antifungal susceptibility analyses were performed. All the isolates belonged to the Cryptococcus gattii sensu stricto (B;VGI) and were identified as a new sequence type (ST) 553 by Multilocus Sequence Typing (MLST) analyses. Susceptibility testing showed that all the strains had a wild-type phenotype for fluconazole, amphotericin B and flucytosine. Treatment with fluconazole (1200mg/day) was initiated with success. CONCLUSION: This is the first case report of the presence of C. gattii sensu stricto VGI in a HIV-negative ivorian patient and the second report of the presence of species from the C. gattii complex species in this country.


Asunto(s)
Antifúngicos/farmacología , Criptococosis/diagnóstico , Cryptococcus gattii/efectos de los fármacos , Cryptococcus gattii/genética , Genotipo , Adulto , Antifúngicos/uso terapéutico , Côte d'Ivoire , Criptococosis/líquido cefalorraquídeo , Criptococosis/tratamiento farmacológico , Criptococosis/microbiología , Cryptococcus gattii/clasificación , Cryptococcus gattii/patogenicidad , Femenino , Variación Genética , Infecciones por VIH , Humanos , Pruebas de Sensibilidad Microbiana
2.
J Mycol Med ; 27(1): 72-78, 2017 Mar.
Artículo en Francés | MEDLINE | ID: mdl-28108201

RESUMEN

OBJECTIVE: Assessing the use of high-dose fluconazol monotherapy (1200mg or 800mg) in the treatment and prognosis of HIV-associated cryptococcal meningitis in Ivory Coast. PATIENTS AND METHODS: A retrospective study carried out from August 2008 to August 2011 based on patients charts suffering from CM in the Abidjan Tropicals and Infectious Disease Unit. Mortality rate and associated factors were analyzed. RESULTS: Forty-six cases of cryptococcal meningitis (2.5% of hospitalizations) were included. The sex-ratio was of 1.2. The median age was 40.5 [35-47] years. The symptomatology was subacute (93.5%). The main clinical symptoms were syndrome of pure meningeal irritation (65%), fever (100%); 35% of patients had encephalomeningits. Twenty-one (45.7%) was ART-naïve patients. Fluconazole 1200mg was prescribed to 29 (63%) patients. Therapeutic lumbar punctures were performed in 42 (91.3) patients. The mortality rate was 50%. Significant predictors of mortality were encephalomeningitis and therapeutic lumbar puncture. CONCLUSION: Cryptococcal meningitis associated mortality remains high despite the use of high-dose fluconazole monotherapy. Therapeutic lumbar punctures help to improving the prognosis.


Asunto(s)
Antifúngicos/administración & dosificación , Fluconazol/administración & dosificación , Meningitis Criptocócica/tratamiento farmacológico , Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Adulto , Côte d'Ivoire/epidemiología , Relación Dosis-Respuesta a Droga , Femenino , VIH , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/epidemiología , Humanos , Masculino , Meningitis Criptocócica/epidemiología , Persona de Mediana Edad , Estudios Retrospectivos
3.
Med Mal Infect ; 45(8): 324-7, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26344815

RESUMEN

OBJECTIVE: We described the use of antiretroviral drugs to prevent HIV transmission among children and adolescents victims of rape in Abidjan (Ivory Coast). MATERIALS AND METHOD: We conducted a retrospective and descriptive study on children (0-9 years) and adolescents (10-19 years) victims of rape between 2000 and 2013. We analyzed the patients' socio-demographic characteristics and the modality of the chemoprophylaxis. RESULTS: We included 10 children and 89 adolescents in the study. The median age was 16 years old (3-19 years). The median time to consultation was 23.5 hours (5-152 hours). The antiretroviral chemoprophylaxis was administered to 92 patients (93%). No HIV and HBV seroconversion was observed after a 3-month follow-up. CONCLUSION: A better management of rape victims is required in Abidjan.


Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Infecciones por VIH/prevención & control , Violación , Adolescente , Fármacos Anti-VIH/administración & dosificación , Niño , Preescolar , Côte d'Ivoire , Femenino , Estudios de Seguimiento , Anticuerpos Anti-VIH/sangre , Infecciones por VIH/transmisión , Seropositividad para VIH , Necesidades y Demandas de Servicios de Salud , Hepatitis B/transmisión , Anticuerpos contra la Hepatitis B/sangre , Humanos , Masculino , Estudios Retrospectivos , Seroconversión , Factores Socioeconómicos , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA